McKesson (NYSE:MCK) Price Target Raised to $925.00

McKesson (NYSE:MCK) had its price objective hoisted by Wells Fargo & Company from $914.00 to $925.00 in a report released on Thursday morning,Benzinga reports. The firm currently has an equal weight rating on the stock.

Other equities analysts also recently issued research reports about the stock. Morgan Stanley reissued an “overweight” rating and issued a $966.00 target price on shares of McKesson in a research note on Thursday, January 29th. Wall Street Zen downgraded McKesson from a “buy” rating to a “hold” rating in a report on Saturday, November 8th. Mizuho raised their price objective on McKesson from $880.00 to $885.00 and gave the company a “neutral” rating in a research report on Thursday. Jefferies Financial Group boosted their price objective on McKesson from $820.00 to $900.00 and gave the stock a “buy” rating in a research note on Monday, October 13th. Finally, Robert W. Baird set a $968.00 target price on McKesson in a research report on Wednesday, January 14th. One analyst has rated the stock with a Strong Buy rating, twelve have assigned a Buy rating and four have assigned a Hold rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $918.93.

McKesson Trading Down 1.0%

Shares of McKesson stock opened at $947.96 on Thursday. The business’s fifty day moving average price is $828.41 and its 200 day moving average price is $780.06. McKesson has a twelve month low of $583.55 and a twelve month high of $971.93. The stock has a market capitalization of $116.12 billion, a P/E ratio of 27.26, a PEG ratio of 1.55 and a beta of 0.40.

McKesson (NYSE:MCK) last released its quarterly earnings data on Wednesday, February 4th. The company reported $9.34 EPS for the quarter, topping analysts’ consensus estimates of $9.19 by $0.15. McKesson had a negative return on equity of 338.97% and a net margin of 1.09%.The company had revenue of $106.16 billion for the quarter, compared to the consensus estimate of $105.98 billion. During the same period last year, the business posted $8.03 EPS. The company’s quarterly revenue was up 11.4% compared to the same quarter last year. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. As a group, sell-side analysts predict that McKesson will post 32.77 EPS for the current year.

McKesson Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, April 1st. Investors of record on Monday, March 2nd will be issued a $0.82 dividend. The ex-dividend date of this dividend is Monday, March 2nd. This represents a $3.28 dividend on an annualized basis and a yield of 0.3%. McKesson’s dividend payout ratio is currently 9.43%.

Insiders Place Their Bets

In other McKesson news, EVP Thomas L. Rodgers sold 276 shares of McKesson stock in a transaction that occurred on Monday, January 5th. The stock was sold at an average price of $816.18, for a total transaction of $225,265.68. Following the sale, the executive vice president directly owned 2,268 shares in the company, valued at $1,851,096.24. The trade was a 10.85% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 0.08% of the stock is currently owned by company insiders.

Institutional Trading of McKesson

A number of hedge funds have recently made changes to their positions in the stock. EverSource Wealth Advisors LLC boosted its stake in McKesson by 1.5% during the 4th quarter. EverSource Wealth Advisors LLC now owns 2,281 shares of the company’s stock valued at $1,870,000 after acquiring an additional 34 shares during the last quarter. Legato Capital Management LLC bought a new stake in shares of McKesson in the 4th quarter worth about $408,000. Lloyd Advisory Services LLC. acquired a new stake in shares of McKesson in the 4th quarter valued at about $1,152,000. Karras Company Inc. acquired a new stake in shares of McKesson in the 4th quarter valued at about $262,000. Finally, RD Lewis Holdings Inc. lifted its position in shares of McKesson by 11.3% during the fourth quarter. RD Lewis Holdings Inc. now owns 837 shares of the company’s stock worth $712,000 after purchasing an additional 85 shares during the last quarter. Institutional investors and hedge funds own 85.07% of the company’s stock.

McKesson News Roundup

Here are the key news stories impacting McKesson this week:

• Positive Sentiment: Q3 results beat consensus: EPS topped estimates and revenue grew ~11.4% year‑over‑year; management raised FY‑2026 adjusted EPS guidance to $38.80–$39.20, underpinning today’s rally. McKesson Q3 Earnings Call Highlights
• Positive Sentiment: Growth drivers called out on the call: oncology, specialty distribution and technology businesses accelerated, which McKesson cites as the basis for the raised profit outlook. MCK Q3 Earnings & Sales Top Estimates, 2026 View Up
• Positive Sentiment: Strong market reaction: analysts and investors pushed the share price sharply higher on the beat + guidance, citing the bigger‑than‑expected lift to FY26 adjusted EPS. How McKesson Stock Surged 17% In A Day
• Neutral Sentiment: Analyst target changes mixed: some firms raised price targets (e.g., Wells Fargo, Mizuho) but ratings stayed neutral/equal‑weight, leaving upside expectations varied among brokers. Price Target Raised to $925.00 at Wells Fargo & Company
• Neutral Sentiment: Company materials and transcripts are available for detailed review (presentation and full earnings call transcript) — useful for checking segment KPIs, margin drivers and guidance assumptions. Q3 2026 earnings call transcript
• Negative Sentiment: Operational cash flow weakness flagged: some reports note weaker operating cash flow despite profit growth, and balance‑sheet metrics (higher liabilities) warrant watching for sustainability of buybacks/dividends. EPS Beats, Profit Growth but Weak Operating Cash Flow
• Negative Sentiment: Insider selling is noted in recent filings; combined with high share price momentum, this can contribute to near‑term volatility or profit‑taking. Insider Trading and Hedge Fund Activity

About McKesson

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.